Skip to main content
TCMDTactile Systems Technology, IncHold6.5·$22.17-1.51%

Tactile Systems Technology (TCMD) Q2 2026 earnings — TrendMatrix coverage

BEAT+111.8% vs estimateEPS $0.36 vs $0.17 estVerdict Buy (Wait)Hold

Reported

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure

Event detail · Q2 2026

Key numbers

Reported EPS
$0.36
Estimate
$0.17
Surprise
+111.8%
Revenue (period 2026-06-30)
$85.7M
Score at report (before → after)
6.86.8/10

Revenue source: xbrl.

Report record · Q2 2026

How the report landed

Tactile Systems Technology (TCMD) beat the $0.17 estimate with diluted EPS of $0.36 — a large 111.8% upside surprise. TrendMatrix's engine moved from Buy (Wait) (6.8/10) to Hold at 6.8/10 after the report.

Current read · as of 2026-09-17

Where TrendMatrix's rating stands now

TrendMatrix currently rates TCMD Hold at 6.5/10.

3 of the last 4 quarters beat the estimate; this quarter's +111.8% surprise compares with a +74.4% four-quarter average. Next scheduled report: 2026-11-02.

What supports the rating

  • Sector modifier (Healthcare): +0.5
  • Strong earnings beat streak (3/4)

What argues against it

  • Concentration risk — Product: lymphedema products (84.0%)
  • Concentration risk — Supplier: single-source component suppliers

This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.

Current engine read

The levels TrendMatrix's engine tracks

Current price
$22.17
Price target
$33.15
Stop
$20.73
Upside to target
+49.5%
Reward-to-risk
7.6:1

The stock trades at 21.0× trailing but 15.5× forward earnings — consensus estimates already build in a substantial earnings recovery.

Risk check: trading volume is running 1.5× its average — elevated turnover around the report window.

Model outputs from TrendMatrix’s engine as of 2026-09-17 — shown for context, not personalized investment advice.

Healthcare context

TCMD at TrendMatrix's latest read

Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.

Industry
Medical Devices
Market cap
$509.9M
P/E (fwd)
15.5
P/E (ttm)
21.0
52-week range
$13.38$37.77
Off 52-week high
41.3%
RSI (14)
31
Volume vs avg
1.50×
Score today
6.5/10

Earnings figures are sourced from TrendMatrix’s pipeline (EPS: existing earnings extraction; revenue: SEC XBRL company facts where available, yfinance-provisional otherwise). Not a buy/sell rating, a price target, or investment advice — see the current verdict on the stock’s main page for TrendMatrix’s live read.

Home Stocks TCMD Earnings Q2 2026 earnings